Insider · CIK 0001736026
Barlow Jane F
Reports to the SEC for 5 companies · SALT LAKE CITY, UT
Transactions
24
Companies
5
Filings
14
CIK
0001736026
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-07-10 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2026-07-10 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2025-06-05 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2025-06-05 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2024-06-20 | VIRXViracta Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2024-06-06 | SERASERA PROGNOSTICS, INC.A Award | — |
| 2024-06-06 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2023-06-08 | VIRXViracta Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2023-06-08 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2022-06-09 | VIRXViracta Therapeutics, Inc. · Stock Option (right to buy)A Award | — |
| 2022-05-17 | CONTRAFECT CorpOptions (Right to Buy)A Award | +$141K |
| 2022-04-11 | SERASERA PROGNOSTICS, INC. · Stock Option (right to buy)A Award | — |
| 2021-08-16 | VIRXViracta Therapeutics, Inc. · Stock Option (Right to Buy)A Award | — |
| 2021-02-08 | CONTRAFECT CorpOPTIONS (RIGHT TO BUY)A Award | — |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-10-01 | MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer | — |
| 2020-06-23 | MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2019-12-11 | MOMENTA PHARMACEUTICALS INCStock Option (Right to Buy)A Award | — |
| 2019-08-12 | TXMDTherapeuticsMD, Inc.P Purchase | +$9,997.92 |
| 2019-06-20 | TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2018-07-02 | TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
| 2018-04-17 | TXMDTherapeuticsMD, Inc. · Non-Qualified Stock Option (right to buy)A Award | — |
Recent filings
- 4Barlow Jane F0001736026-26-000002SEC(opens sec.gov)
- 4Barlow Jane F0000950170-25-083332SEC(opens sec.gov)
- 4Barlow Jane F0000950170-24-076994SEC(opens sec.gov)
- 4Barlow Jane F0001534969-24-000131SEC(opens sec.gov)
- 4Barlow Jane F0001534969-23-000079SEC(opens sec.gov)
- 4Barlow Jane F0001209191-23-036000SEC(opens sec.gov)
- 4Barlow Jane F0001209191-22-035950SEC(opens sec.gov)
- 4Barlow Jane F0001209191-22-030285SEC(opens sec.gov)
- 4Barlow Jane F0001534969-22-000050SEC(opens sec.gov)
- 4Barlow Jane F0001209191-21-052009SEC(opens sec.gov)
- 4Barlow Jane F0000899243-21-006062SEC(opens sec.gov)
- 4Barlow Jane F0001179110-20-010058SEC(opens sec.gov)
- 4Barlow Jane F0001179110-20-007753SEC(opens sec.gov)
- 4Barlow Jane F0001179110-19-012740SEC(opens sec.gov)
Companies
Address
C/O SERA PROGNOSTICS, INC. 2749 EAST PARLEYS WAY, SUITE 200
SALT LAKE CITY, UT, 84109